Deveron Corp. (TSXV:FARM) Completes Asset Sale

Toronto, Ontario — February 14, 2026 — Leads & Copy — Deveron Corp. (TSXV: FARM) has completed the sale of substantially all of its assets, according to a news release.

The transaction follows previous press releases from November 3, 2025, December 19, 2025, and December 30, 2025.

The sale was conducted in accordance with a share and asset purchase agreement with RRL Ultimate Parent, LLC (“Parent”), 1001388516 Ontario Inc. (“BidCo” and together with Parent, the “Share Purchasers”), Maple NewCo, LLC (the “US Buyer” and together with the Share Purchasers, the “Purchasers”), Deveron USA, LLC (“Deveron USA”), Woods End Laboratories, LLC (“Woods End”, and together with Deveron USA, the “Asset Vendors” and together with the Company, the “Vendors”), and certain minority vendors (collectively, the “Minority Vendors”).

Deveron anticipates that it will be subject to migration to the NEX Board of the TSXV upon completion of the transaction unless it can demonstrate that it meets “Continued Listing Requirements” (CLR) as defined under applicable TSXV policies. The company has not yet acquired or developed any such business and cannot assure that it will do so before its listing is migrated from Tier 2 to NEX, or at all.

Additional details on the transaction are available in the company’s management information circular dated December 1, 2025, filed on SEDAR+.

Deveron is an agriculture technology company that provides data and insights to help farmers and large agriculture enterprises increase yields, reduce costs, and improve farm outcomes. The company uses a digital process that leverages data collected on farms across North America to drive unbiased interpretation of production decisions, ultimately recommending how to optimize input use.

David MacMillan is the President & CEO of Deveron Corp.

Source: Deveron Corp.

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.